Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hormone replacement therapy].

Kotaro Azuma1, Satoshi Inoue

  • 1Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo/Growth Factor Division, National Cancer Center Research Institute, Toklyo, Japan.

Clinical Calcium
|December 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A Case of Two Episodes of Intraperitoneal Metastasis after Surgery for Breast Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same author

Vitamin K Insufficiency Predicts Cognitive Decline in Community-Dwelling Older Adults: The Otassha Study.

Geriatrics & gerontology international·2025
Same author

Positive Immunoreactivities of TM9SF1 and EBAG9 are Associated With Poor Prognosis in Patients With Triple-Negative Breast Cancer.

Clinical breast cancer·2025
Same author

[A Case of Perforated Low-Grade Appendiceal Mucinous Neoplasm Diagnosed During Appendectomy].

Gan to kagaku ryoho. Cancer & chemotherapy·2024
Same author

Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

EBAG9-deficient mice display decreased bone mineral density with suppressed autophagy.

iScience·2024
Same journal

[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.]

Clinical calcium·2019
Same journal

[Sequential treatment of osteoporosis with anti-sclerostin.]

Clinical calcium·2019
Same journal

[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]

Clinical calcium·2019
Same journal

[Wnt signaling in myeloma.]

Clinical calcium·2019
Same journal

[Fate decision of hematopoietic stem cells by Wnt signaling.]

Clinical calcium·2019
Same journal

[Control of inflammatory bone destruction by targeting the Wnt signaling pathway.]

Clinical calcium·2019
See all related articles

Hormone Replacement Therapy (HRT) improves bone density but increases risks of breast cancer and cardiovascular disease. Low-dose HRT and selective estrogen receptor modulators (SERMs) are being investigated as safer alternatives.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Women's Health

Context:

  • Postmenopausal women experience estrogen depletion, impacting bone health and increasing fracture risk.
  • Hormone Replacement Therapy (HRT) traditionally uses estrogen, often with progestin, to manage menopausal symptoms and bone loss.
  • Recent U.S. studies have raised concerns about HRT's safety profile.

Purpose:

  • To evaluate the efficacy and safety of Hormone Replacement Therapy (HRT) in postmenopausal women.
  • To analyze the impact of HRT on bone mineral density and fracture risk.
  • To assess the risks of breast cancer and cardiovascular diseases associated with HRT.

Summary:

  • Estrogen in HRT inhibits bone resorption, improving bone mineral density and reducing osteoporotic fractures.

Related Experiment Videos

  • Large-scale clinical studies indicate HRT increases risks for breast cancer and atherosclerotic cardiovascular diseases.
  • Current evidence suggests HRT benefits may not outweigh risks, except for managing vasomotor symptoms.

    • Impact:

    • HRT's established benefits for bone health are contrasted with newly identified significant risks.
    • The findings necessitate a re-evaluation of HRT's role in postmenopausal care.
    • Investigational approaches like low-dose HRT and selective estrogen receptor modulators (SERMs) aim to mitigate these risks.